| Net sales | 7,678.6a | 7,394.2a | 6,939.9a |
| Cost of products sold, excluding intangible asset amortization | -2,191.2a | -2,083.8a | -2,019.5a |
| Intangible asset amortization | -591.9a | -561.5a | -526.8a |
| Research and development | -437.4a | -458.7a | -406a |
| Selling, general and administrative | -2,929.8a | -2,838.9a | -2,761.7a |
| Goodwill and intangible asset impairment | 0a | 0a | -292.8a |
| Restructuring and other cost reduction initiatives | -219a | -151.9a | -191.6a |
| Quality remediation | 0a | 0a | -33.8a |
| Acquisition, integration, divestiture and related | -23.6a | -21.7a | -11.4a |
| Operating expenses | -6,392.9a | -6,116.5a | -6,243.6a |
| Operating profit | 1,285.7a | 1,277.7a | 696.3a |
| Other expense, net | -31.1a | -9.3a | -128a |
| Interest expense, net | -218a | -201.2a | -164.8a |
| Earnings from continuing operations before income taxes | 1,036.6a | 1,067.3a | 403.5a |
| Provision for income taxes from continuing operations | -131.4a | -42.2a | -112.3a |
| Net earnings from continuing operations | 905.2a | 1,025.1a | 291.2a |
| Less: Net earnings attributable to noncontrolling interest | 1.5a | 1.1a | 1a |
| Net earnings from continuing operations of Zimmer Biomet Holdings, Inc. | 903.8a | 1,024a | 290.2a |
| Loss from discontinued operations, net of tax | 0a | 0a | -58.8a |
| Net earnings of Zimmer Biomet Holdings, Inc. | 903.8a | 1,024a | 231.4a |